Carl Garner, PhD,
VP of Regulatory Affairs, Eli Lilly
Latest
There is no content for this search. Please update your filters and try again.
More from the U.S. Chamber
- Survey Affirms Americans’ Support for Trade
Contrary to the political debate in Washington, most Americans say they benefit significantly from international trade.
- Germany’s Economic Moment of Reckoning
Germany’s weak economy and strict limits on debt financing have failed to generate the revenues required to meet an urgent list of priorities.
- Why Biodiversity Matters for Business
Business showed up in record numbers at the UN's Convention on Biological Diversity, advancing bold solutions to balance conservation with business realities.
